Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Blood Sugar Take Care and Glucose Metabolism
Effect of Blood Sugar Take Care on Glucose Metabolism, Determinants of Metabolic Syndrome, and Quality of Life in Prediabetic Adults: A Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated:  5/22/2012
SPRIM
mi
from
San Francisco, CA
Blood Sugar Take Care and Glucose Metabolism
Effect of Blood Sugar Take Care on Glucose Metabolism, Determinants of Metabolic Syndrome, and Quality of Life in Prediabetic Adults: A Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 5/22/2012
SPRIM
mi
from
San Francisco, CA
Click here to add this to my saved trials
Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes
Postpartum Glucose Tolerance in Women With Recent Gestational Diabetes Using the Levonorgestrel IUD and Non-Hormonal Contraception: A Prospective Cohort Study
Status: Enrolling
Updated:  5/23/2012
Northwestern Medical Faculty Foundation; Northwestern Memorial Hospital
mi
from
Chicago, IL
Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes
Postpartum Glucose Tolerance in Women With Recent Gestational Diabetes Using the Levonorgestrel IUD and Non-Hormonal Contraception: A Prospective Cohort Study
Status: Enrolling
Updated: 5/23/2012
Northwestern Medical Faculty Foundation; Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
A Pilot Study to Improve Patient-Doctor Communication
A Pilot Study to Improve Patient-Doctor Communication
Status: Enrolling
Updated:  5/23/2012
Walter Reed National Medical Military Center (WRNMMC)
mi
from
Bethesda, MD
A Pilot Study to Improve Patient-Doctor Communication
A Pilot Study to Improve Patient-Doctor Communication
Status: Enrolling
Updated: 5/23/2012
Walter Reed National Medical Military Center (WRNMMC)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes
Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes
Status: Enrolling
Updated:  5/24/2012
Emory University School of Nursing
mi
from
Atlanta, GA
Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes
Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes
Status: Enrolling
Updated: 5/24/2012
Emory University School of Nursing
mi
from
Atlanta, GA
Click here to add this to my saved trials
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Pilot Study Using Secretin and Iodinated Intravenous Contrast and 64-Channel CT in Patients at High Risk for Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  5/25/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Pilot Study Using Secretin and Iodinated Intravenous Contrast and 64-Channel CT in Patients at High Risk for Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 5/25/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs
Status: Enrolling
Updated:  5/30/2012
Georgetown University Hospital
mi
from
Washington,
RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs
Status: Enrolling
Updated: 5/30/2012
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
Effect of Androgel on Inflammatory Mediators and Oxidative Stress in Type 2 Diabetic Males With Hypogonadism
Status: Enrolling
Updated:  6/5/2012
Diabetes-Endocrinology Center of Western NY, 3 Gates Circle
mi
from
Buffalo, NY
Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
Effect of Androgel on Inflammatory Mediators and Oxidative Stress in Type 2 Diabetic Males With Hypogonadism
Status: Enrolling
Updated: 6/5/2012
Diabetes-Endocrinology Center of Western NY, 3 Gates Circle
mi
from
Buffalo, NY
Click here to add this to my saved trials
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI:Effects on Oxidative Stress and Inflammation.
Status: Enrolling
Updated:  6/5/2012
Diabetes - Endocrinology Center of Western New York
mi
from
Buffalo, NY
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI:Effects on Oxidative Stress and Inflammation.
Status: Enrolling
Updated: 6/5/2012
Diabetes - Endocrinology Center of Western New York
mi
from
Buffalo, NY
Click here to add this to my saved trials
The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
Status: Enrolling
Updated:  6/5/2012
Diabetes and endocrinology Center of WNY
mi
from
Buffalo, NY
The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
Status: Enrolling
Updated: 6/5/2012
Diabetes and endocrinology Center of WNY
mi
from
Buffalo, NY
Click here to add this to my saved trials
Exeantide in Type 2 Diabetes on Insulin
The Effect of Exenatide on Insulin Requirement, Weight and Inflammation in Obese Type 2 Diabetic Subjects on Insulin
Status: Enrolling
Updated:  6/5/2012
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Exeantide in Type 2 Diabetes on Insulin
The Effect of Exenatide on Insulin Requirement, Weight and Inflammation in Obese Type 2 Diabetic Subjects on Insulin
Status: Enrolling
Updated: 6/5/2012
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Resveratrol in Type2 Diabetes and Obesity
Effect of Resveratrol on Insulin Resistance and Inflammatory Mediators in Obese and Type 2 Diabetic Subjects
Status: Enrolling
Updated:  6/5/2012
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Resveratrol in Type2 Diabetes and Obesity
Effect of Resveratrol on Insulin Resistance and Inflammatory Mediators in Obese and Type 2 Diabetic Subjects
Status: Enrolling
Updated: 6/5/2012
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Status: Enrolling
Updated:  6/5/2012
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Status: Enrolling
Updated: 6/5/2012
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Status: Enrolling
Updated:  6/5/2012
Johns Hopkins University
mi
from
Baltimore, MD
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Status: Enrolling
Updated: 6/5/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Status: Enrolling
Updated:  6/5/2012
Johns Hopkins University
mi
from
Baltimore, MD
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination
Status: Enrolling
Updated: 6/5/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Birmingham, AL
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Phoenix, AZ
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Little Rock, AR
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
San Diego, CA
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Atlanta, GA
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Meridian, ID
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Anderson, IN
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Anderson, IN
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
New Orleans, LA
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Baltimore, MD
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
St Louis, MO
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Kalispell, MT
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Kalispell, MT
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Henderson, NV
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Bronx, NY
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Asheville, NC
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Bismarck, ND
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Bismarck, ND
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Akron, OH
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Houston, TX
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2012
Clinical Research Facility
mi
from
Annandale, VA
AMG 151 Amgen Protocol Number 20100761
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2012
Clinical Research Facility
mi
from
Annandale, VA
Click here to add this to my saved trials
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
Intensive Diabetes Clinic and Intermittent Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes Mellitus in Poor Glycemic Control
Status: Enrolling
Updated:  6/12/2012
Uhcmc
mi
from
Cleveland, OH
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
Intensive Diabetes Clinic and Intermittent Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes Mellitus in Poor Glycemic Control
Status: Enrolling
Updated: 6/12/2012
Uhcmc
mi
from
Cleveland, OH
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Arkansas Diabetes Clinic and Research Center
mi
from
Little Rock, AR
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Arkansas Diabetes Clinic and Research Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
AMCR Institute, Inc
mi
from
Escondido, CA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
AMCR Institute, Inc
mi
from
Escondido, CA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Frank Diabetes Research Institute/ Mills-Peninsula Health Center
mi
from
San Mateo, CA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Frank Diabetes Research Institute/ Mills-Peninsula Health Center
mi
from
San Mateo, CA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
University of Colorado Denver/ Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
University of Colorado Denver/ Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Metabolic Research Institute
mi
from
West Palm Beach, FL
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Metabolic Research Institute
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Physicians Research Associates
mi
from
Lawrenceville, GA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Physicians Research Associates
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Endocrine Research Solutions
mi
from
Roswell, GA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Endocrine Research Solutions
mi
from
Roswell, GA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Rocky Mountains Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Rocky Mountains Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Iowa Diabetes and Endocrinology Research Center
mi
from
Des Moines, IA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Iowa Diabetes and Endocrinology Research Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
International Diabetes Center
mi
from
Minneapolis, MN
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
International Diabetes Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Naomie Barrie Diabetes Center
mi
from
New York, NY
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Naomie Barrie Diabetes Center
mi
from
New York, NY
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Joslin Diabetes Center
mi
from
Syracuse, NY
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Joslin Diabetes Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Ohio University College Of Osteopathic Medicine
mi
from
Athens, OH
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Ohio University College Of Osteopathic Medicine
mi
from
Athens, OH
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Texas Diabetes
mi
from
Austin, TX
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Texas Diabetes
mi
from
Austin, TX
Click here to add this to my saved trials